135206-84-7 Usage
Description
2,2-Difluoroethyl P-Toluenesulfonate is an organic compound that serves as a valuable reagent in the synthesis of various chemical compounds, particularly in the pharmaceutical and agrochemical industries. It is characterized by its unique chemical structure, which includes a difluoroethyl group and a p-toluenesulfonate group, providing it with specific reactivity and properties that make it useful in a range of applications.
Uses
Used in Pharmaceutical Industry:
2,2-Difluoroethyl P-Toluenesulfonate is used as a synthetic reagent for the preparation of various pharmaceutical compounds. Its unique chemical structure allows it to participate in a variety of reactions, such as substitution, addition, and elimination reactions, which are crucial for the synthesis of complex organic molecules with potential therapeutic applications.
Used in Agrochemical Industry:
2,2-Difluoroethyl P-Toluenesulfonate is used as a reagent in the preparation of (difluorophenyl)[(arylmethyl)thio](triazolyl)butanol fungicides. These fungicides are designed to protect crops from fungal infections, which can lead to significant yield losses and reduced crop quality. The use of 2,2-Difluoroethyl P-Toluenesulfonate in the synthesis of these fungicides contributes to the development of effective and targeted crop protection agents.
Check Digit Verification of cas no
The CAS Registry Mumber 135206-84-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,2,0 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 135206-84:
(8*1)+(7*3)+(6*5)+(5*2)+(4*0)+(3*6)+(2*8)+(1*4)=107
107 % 10 = 7
So 135206-84-7 is a valid CAS Registry Number.
135206-84-7Relevant articles and documents
HPK1 ANTAGONISTS AND USES THEREOF
-
Paragraph 1078; 1079, (2021/03/19)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
Method for preparing hydrofluoroether through two-step process
-
Paragraph 0058; 0059; 0070; 071, (2019/07/10)
The invention discloses a method for preparing hydrofluoroether through a two-step process. With the method provided by the invention, p-toluensulfonyl chloride and fluorine-containing alcohol are subjected to a reaction to obtain p-toluenesulfonate, and the p-toluenesulfonate and sodium alkoxide are subjected to a Williamson ether synthetic reaction to obtain the hydrofluoroether. The method disclosed by the invention has the advantages of cheap and low-toxicity raw materials, mild and controllable reaction conditions, and high yield.
METHYL OXAZOLE OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 33, (2016/06/28)
The present invention is directed to methyl oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.